CTCF ChIA-PET in Panc1 For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03

NIAID Data Ecosystem20

Supplementary Tables 1 - 4 from CHD7 Expression Predicts Survival Outcomes in Patients with Resected Pancreatic Cancer

胰腺癌基因组学

肿瘤药物敏感性筛选

XLS file - 675KB, Full Results of Primary Gemcitabine Sensitivity Screen (S1). Known DNA Damage Response Genes Identified as Hits in Gemcitabine Sensitivity Screen (S2). Dysregulation, Differential Ex

Figshare2014-05-15 更新10

Most frequently (>70%) detected regions of gain, loss and LOH in PDAC genotyped on the Affymetrix 500 K SNP array platform (n = 20).

胰腺癌基因组学

SNP阵列变异检测

*Only cancer-associated genes (in bold) or genes related to pancreas (underlined) are shown.

Figshare2015-12-02 更新20

Supplementary Table S1 from A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial

胰腺癌基因组学

个性化治疗

Supplementary Table 1. Custom virtual gene panel included in the whole exome sequencing analysis

Figshare2025-01-17 更新10